Bio-Rad Laboratories, Inc.

Historical 13F Holders

Symbol
BIO
CUSIP
090572207
All holders as of
Q2 2026
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 090572207 since 12/18/2024, largest first.

Filer % of Class Filed
Norman D. Schwartz 13D/A
97.2% 10/30/2025
Event 9/25/2025
Alice N. Schwartz 13D/A
12.3% 7/18/2025
Event 5/1/2025
First Eagle Investment Management, LLC 13G/A
11.4% 8/6/2025
Event 6/30/2025
BlackRock, Inc. 13G/A 7.4% 10/17/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 10 3.84 k $1.45 M
2026 Q2 410 28.3 M $6.55 B
2026 Q1 405 20.0 M $5.57 B
2025 Q4 410 19.7 M $5.95 B
2025 Q3 407 19.5 M $5.48 B
2025 Q2 398 19.4 M $4.67 B
2025 Q1 452 19.5 M $4.71 B
2024 Q4 472 18.8 M $6.17 B
2024 Q3 461 19.5 M $6.53 B
2024 Q2 461 20.1 M $5.48 B
2024 Q1 495 19.1 M $6.60 B
2023 Q4 512 19.0 M $6.12 B
2023 Q3 489 18.8 M $6.74 B
2023 Q2 491 18.8 M $7.16 B
2023 Q1 530 19.2 M $9.21 B
2022 Q4 493 20.2 M $8.51 B
2022 Q3 508 19.5 M $8.14 B
2022 Q2 523 19.1 M $9.46 B
2022 Q1 540 19.2 M $10.8 B
2021 Q4 563 19.2 M $14.5 B
2021 Q3 538 19.4 M $14.5 B
2021 Q2 534 19.4 M $12.5 B
2021 Q1 515 19.6 M $11.2 B
2020 Q4 517 19.8 M $11.6 B
2020 Q3 497 19.3 M $9.94 B
2020 Q2 494 19.4 M $8.73 B
2020 Q1 427 19.2 M $6.74 B
2019 Q4 407 19.3 M $7.11 B
2019 Q3 375 19.4 M $6.45 B
2019 Q2 359 18.9 M $5.90 B
2019 Q1 366 19.5 M $5.95 B
2018 Q4 340 19.3 M $4.49 B
2018 Q3 361 19.4 M $6.07 B
2018 Q2 338 19.4 M $5.59 B
2018 Q1 327 19.6 M $4.90 B
2017 Q4 311 19.2 M $4.59 B
2017 Q3 278 19.2 M $4.27 B
2017 Q2 280 18.8 M $4.26 B
2017 Q1 281 19.1 M $3.81 B
2016 Q4 270 20.6 M $3.75 B
2016 Q3 250 19.2 M $3.14 B
2016 Q2 244 19.1 M $2.74 B
2016 Q1 241 18.9 M $2.59 B
2015 Q4 248 19.0 M $2.63 B
2015 Q3 251 19.0 M $2.55 B
2015 Q2 229 18.7 M $2.81 B
2015 Q1 222 18.9 M $2.55 B
2014 Q4 220 19.0 M $2.29 B
2014 Q3 205 18.7 M $2.12 B
2014 Q2 211 18.6 M $2.23 B
2014 Q1 201 18.1 M $2.32 B